跳至主要内容
临床试验/JPRN-UMIN000026235
JPRN-UMIN000026235已完成2 期

The efficacy of Traditional Japanese Medicine"keishikasyakuyakuto" for irritable bowel syndrome:A multi-center, double-blinded, placebo-controlled, randomized trial - The efficacy of "keishikasyakuyakuto"for IBS:A multi-center,double-blinded,placebo-controlled,randomized trial

Yokohama City University School of Medicine Department of Gastroenterology and Hepatology0 个研究点目标入组 300 人开始时间: 2017年2月20日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1, Patients who had history of gastrointestinal tract resection 2, Patients who have severe complications 3, Patients who have history or current evidence of celiac disease or inflammatory bowel disease 4, Patients who under treatment with steroid or biological products 5, Patients who have severe psychiatric disease 6, Patients who have current evidence of abuse of drugs or alcohol 7, Patients who have history of Kampo allergies 8, Patients who had taken new drug therapy within 4 weeks before entry 10, Patients who had any change in types, dosage,or adiministration of their prescribed drugs within 4 weeks before entry 11, Patients who or are going to take new medicines 12, Patients who have been enrolled in previous clinical trials of Keishikashakuyakuto or have taken Keishikashakuyakuto before entry this trial 13, Patients who or are going to be participating in other clinical studies 14, Patients who are pregnant or possibly pregnant 15, Patients who are lactating 16, Patients who are judged as inadequately for study entry

研究者

发起方
Yokohama City University School of Medicine Department of Gastroenterology and Hepatology

相似试验